High cholesterol concentration is a major risk factor for cardiovascular disease (CVD), and consumption of fish has been associated with a lower CVD risk in several studies. The beneficial health effects of consuming fish have traditionally been ascribed to the long-chain PUFA (LC-PUFA) EPA (C20:5n-3) and DHA (C22:6n-3), although consumption of fish oils or concentrates with high EPA and DHA contents does not affect the cholesterol concentration in humans and lowers the cholesterol concentration in rats and mice only when given in very high doses. Fish oils contain a plethora of fatty acids besides EPA and DHA, and in recent years, increased focus has been on the long-chain MUFA (LC-MUFA) cetoleic acid (C22:1n-11). Cetoleic acid is found in high amounts in oils from certain fish species such as herring, which has relatively low contents of both EPA and DHA. The investigators have recently summarised and meta-analysed the available literature that investigates the effects of diets containing fish oils or fish oil concentrates that have a high content of cetoleic acid but low or no content of EPA and DHA on cholesterol concentration in rodents, showing that cetoleic acid-rich fish oils and concentrates prevent high cholesterol concentration.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
80
Capsules containing herring oil concentrate, taken daily for 8 weeks.
Capsules containing control oil, taken daily for 8 weeks.
University of Bergen
Bergen, Norway
Serum concentration of LDL-cholesterol
LDL-cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
Serum concentration of HDL-cholesterol
HDL-cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
Serum concentration of total cholesterol
Total cholesterol will be measured in fasting serum samples
Time frame: 8 weeks
Serum concentrations of apolipoproteins
Lipoproteins will be measured in fasting serum samples
Time frame: 8 weeks
Serum concentrations of amino acids metabolites
Metabolites of amino acids will be measured in fasting serum samples
Time frame: 8 weeks
Serum concentration of one-carbon pathway metabolites
Metabolites in the one-carbon pathway will be measured in fasting serum samples
Time frame: 8 weeks
Fatty acid composition in leukocytes
Leukocytes will be isolated from fasting serum before quantification of fatty acids
Time frame: 8 weeks
Serum concentration of glucose
Glucose will be measured in serum sampled in fasting condition
Time frame: 8 weeks
Serum concentration of insulin
Insulin will be measured in serum sampled in fasting condition
Time frame: 8 weeks
Body composition
Percent body fat will be measured using bioimpedance
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.